McKesson Prescription Technology Solutions — Goodwill acquired increased by 721.1% to $39.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 721.1%, from $4.75M to $39.00M. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates active inorganic growth and investment in new capabilities, while zero indicates a focus on organic growth or lack of recent M&A.
Tracks the addition of new goodwill to the balance sheet resulting from recent acquisitions within the Prescription Tech...
Used by investors to track the pace and scale of M&A activity compared to industry peers.
mck_segment_prescription_technology_solutions_goodwill_acquired| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $4.75M | $4.75M | $4.75M | $4.75M | $39.00M |
| QoQ Change | — | — | — | — | — | — | — | — | — | +0.0% | +0.0% | +0.0% | +721.1% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | +721.1% |